logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
12/16/2019 8:06:19 AM Gilead Sciences Announces Topline Results From The 48-week, Phase 2 ATLAS Study
12/11/2019 8:33:58 AM Kite And Kiniksa Enter Clinical Collaboration To Conduct Phase 2, Multicenter Study Of Mavrilimumab
11/21/2019 8:33:53 AM Charles Calderaro To Join Kite As Global Head Of Technical Operations
11/8/2019 8:05:19 AM Gilead Sciences Announces New Data From Nonalcoholic Steatohepatitis Research And Development Program
11/8/2019 8:04:30 AM Gilead Announces New Data From Viral Hepatitis Research Program
10/28/2019 8:03:13 AM Gilead And Glympse Bio Announce Strategic Collaboration In Nonalcoholic Steatohepatitis Clinical Development
10/24/2019 4:09:52 PM Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.63 , Record Date 12/13/2019
10/24/2019 4:08:25 PM Gilead Sciences Q3 Loss Per Share $0.92 Vs EPS $1.60 Last Year
10/15/2019 8:41:31 AM Gilead Sciences Names Andrew Dickinson CFO
10/8/2019 2:29:27 AM Gilead Sciences Submits NDA For Filgotinib For Rheumatoid Arthritis In Japan
10/7/2019 8:34:24 AM Gilead Sciences Appoints Merdad Parsey As Chief Medical Officer
  
 
>